About us
About us
The UK's lung charity fighting for your right to breathe
Who we are
Find out who we are and how we help people with lung conditions and asthma.
Our latest work
Read our policy reports and find evidence about how we can improve lung health for all.
Our impact
Together, we are changing the world. In 2024 we invested £3.5 million into vital research and 20,000 people received support from our Helpline team
What we stand for
We are fighting to transform lung health and make sure it gets the attention it deserves.
Our leadership team
Meet Asthma + Lung UK's Chief Executive, Directors and Trustees, leading the fight for your right to breathe
Work with us
Jobs and career opportunities with Asthma + Lung UK.
Contact us
Find out how to contact Asthma + Lung UK expert teams.
Media
Contact the media team at Asthma + Lung UK for any press enquiries. We offer spokespeople, case studies and statistics on lung disease.
Annual reports + accounts
Download our audited accounts and previous annual reports.
About our health information
Learn more about how we make sure our health information is accurate, up-to-date and easy to use.
Blog
Research
Why do the lungs age faster in COPD and how can we slow it down?
We know the lungs of people with COPD age faster than in other people. Dr Justine Devulder is trying to find out why, and whether this can help find new treatments to slow down the progression of COPD.
Research
Could laughter be the best medicine for bronchiectasis?
Can we make treatment fun for people living with bronchiectasis? Dr Arietta Spinou is trying to find out.
Research
What’s the link between bacteria and IPF and how can it unlock new treatments?
Idiopathic pulmonary fibrosis (IPF) is a lung condition that causes scarring in the lungs. Professor Philip Molyneux at Imperial College London is looking at why people with IPF have more bacteria in the lungs and how understanding this can help us develop new treatments.